Oasmia Pharmaceutical AB
(Other OTC/NBB : OASM)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc.
-1.10%22.5514.1%$132.69m
MDCOMedicines Company
1.79%56.9920.3%$112.54m
GWPHGW Pharmaceuticals PLC Sponsored ADR
-0.85%118.116.2%$94.56m
AMRNAmarin Corporation Plc Sponsored ADR
-1.59%16.131.8%$85.93m
JAZZJazz Pharmaceuticals Plc
-1.22%119.652.3%$61.76m
SAGESAGE Therapeutics, Inc.
-3.38%139.938.6%$54.92m
PRGOPerrigo Co. Plc
-0.92%53.896.8%$50.17m
PCRXPacira Pharmaceuticals, Inc.
-0.18%38.8510.5%$47.33m
ENDPEndo International Plc
0.93%4.888.8%$45.03m
UTHRUnited Therapeutics Corporation
0.58%82.1414.3%$37.99m
HZNPHorizon Pharma plc
-3.79%27.406.6%$35.99m
CTLTCatalent Inc
-2.25%48.612.4%$35.36m
ICLRICON Plc
-0.04%141.994.1%$35.20m
ICPTIntercept Pharmaceuticals, Inc.
1.03%65.0716.9%$30.80m
AERIAerie Pharmaceuticals, Inc.
-3.48%20.516.8%$29.48m

Company Profile

Oasmia Pharmaceutical AB engages in the research and development of drugs. It formulates pharmaceutical products for ovarian and breast cancer for humans and cancer for animals. The company was founded by Julian Aleksov and Bo Cederstrand on April 15, 1988 and is headquartered in Uppsala, Sweden.